DRUG · Mapped RxNorm record
Dupilumab
Normalized identity: dupilumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Real Life Experience Survey of Dupilumab in the Netherlands
NCT05331755
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedReal Life Experience Survey of Dupilumab in the Netherlands
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Severe Asthmaunresolved
Interventions
DupilumabDRUG · verified · RxNorm: dupilumab
Sponsors & collaborators
Gert-Jan Braunstahllead sponsor
Genzyme, a Sanofi Companycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05331755 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.